Akums Drugs and Pharmaceuticals Limited is a leading pharmaceutical contract development and manufacturing organization (CDMO) that provides extensive pharmaceutical products and services in India and internationally. The company offers end-to-end solutions for product development, manufacturing, and R&D of formulations. It prepares and submits regulatory dossiers for both Indian and global markets and provides various testing …
IPO - Angel One - Page 207

NSE Introduces 90% Price Cap on SME IPOs: Pros and Cons
4 July 2024Introduction The National Stock Exchange of India Ltd. (NSE) has announced a significant regulatory change aimed at standardizing the price discovery mechanism for Initial Public Offers (IPOs) on the SME platform. This article delves into the details of this new measure, its implications, both positive and negative, and the reasons behind its implementation. The New …

Bansal Wire Industries Lists at 39% Premium at Rs 356 per share on NSE!
10 July 2024Bansal Wire Industries Limited specializes in manufacturing stainless steel wire, debuted on the Indian stock market today. The stock of Bansal Wire Industries settled at Rs 352.05 per share on the BSE, representing an impressive 37.52% premium over the final issue price of Rs 256 per share. Additionally, on the NSE, the company’s shares opened …

Emcure Pharma IPO Listed At 31.5% Premium
10 July 2024Emcure Pharma’s successful debut impressed investors and analysts on the stock exchange, reflecting strong confidence in the company’s growth prospects and management team. The premium opening price of Rs. 1325.05 indicated strong demand for the stock, with investors eager to capitalize on Emcure Pharma’s potential in the pharmaceutical industry. This strong outlook for the stock …

SEBI Delays Crizac Ltd.’s Rs.1000 Cr IPO
23 July 2024Crizac Ltd., a student recruitment solution provider based in Kolkata, has encountered a significant hurdle in its plans to launch a Rs 1,000-crore initial public offering (IPO). The Securities and Exchange Board of India (SEBI) has returned the draft documents, causing a delay in the company’s initial share sale. This IPO was intended to be …

Stallion India Fluorochemicals Secures SEBI Approval for IPO
23 July 2024Stallion India Fluorochemicals has received the green light from the Securities and Exchange Board of India (SEBI) to raise capital through an initial public offering (IPO). The company plans to issue new equity shares and conduct an offer-for-sale, as detailed in their draft red herring prospectus. IPO Details and Allocation of Funds Stallion India Fluorochemicals …

NSE EMERGE Reaches a Milestone with its 500th SME Listing: Average IPO Size Triples
24 July 2024Introduction In a significant development for the Indian stock market, the National Stock Exchange of India Limited (NSE) has achieved a landmark with the listing of its 500th SME company on the NSE EMERGE platform. This milestone highlights the growing importance and success of SME companies in India’s economic landscape. The 500th Listing: Prizor Viztech …

Sai Life Science Files for IPO with SEBI
16 July 2024Sai Life Science Ltd., a Hyderabad-based global pharmaceutical company backed by TPG Group, has filed preliminary papers with the Securities and Exchange Board of India (SEBI) for an initial public offering (IPO). This significant step will help the company raise funds to support its growth and operational needs. IPO Details and Shareholder Information Sai Life …

HDFC Bank Approves HDFC Financial Services IPO
22 July 2024In October 2022, the Reserve Bank of India (RBI) mandated that Non-Banking Financial Companies (NBFCs) belonging to the upper layer (UL) of the system should be listed publicly on the exchange by the end of September 2025. As a result, we have observed HDFC Bank Ltd., one of India’s largest private sector banks, taking steps …

Emcure Pharmaceuticals IPO Receives 67.84x Subscription on Last Day
15 July 2024Today, on the last day of the bidding process, Emcure Pharmaceuticals Limited IPO was subscribed 67.84 times. The retail portion was subscribed to 7.33x, 191.24x in Qualified Institutional Buyers (QIB), 49.28x in Non-Institutional Investors (NII), and 8.78x in the employees category. Here’s a table to understand the day-wise subscription Date QIB NII Retail EMP Total …
